SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Fukayama M, Chong JM, Kaizaki Y. Epstein-Barr virus and gastric carcinoma. Gastric Cancer 1998; 1: 10414.
  • 2
    Fukayama M, Chong JM, Uozaki H. Pathology and molecular pathology of Epstein-Barr virus-associated gastric carcinoma. In: TakadaK, editor. Epstein-Barr virus and human cancer. Berlin: Springer-Verlag, 2001. 91102.
  • 3
    Fukayama M, Hayashi Y, Iwasaki Y, Chong JM, Ooba T, Takizawa T, Koike M, Mizutani S, Miyaki M, Hirai K. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest 1994; 7: 7381.
  • 4
    Chong JM, Sakuma K, Sudo M, Osawa T, Ohara E, Uozaki H, Shibahara J, Kuroiwa K, Tominaga S, Hippo Y, Aburatani H, Funata N, et al. Interleukin1β expression in human gastric carcinoma with Epstein-Barr virus infection. J Virol 2002; 76: 682531.
  • 5
    Chong JM, Fukayama M, Hayashi Y, Funata N, Takizawa T, Koike M, Muraoka M, Kikuchi-Yanoshita M, Mizuno S. Expression of CD44 variants in gastric carcinoma with or without Epstein-Barr virus. Int J cancer 1997; 74: 4504.
  • 6
    Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T. Transcriptional analysis of the Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumor cells. Br J Cancer 1996; 74: 62531.
  • 7
    zur Hausen A, Brink AATP, Craanen ME, Middeldrop JM, Meijer CJLM, van den Brule AJC. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res 2000; 60: 27458.
  • 8
    Chong JM, Fukayama M, Hayashi Y, Takizawa T, Koike M, Konishi M, Kikuchi-Yanoshita R, Miyaki M. Microsatellite instability in the progression of gastric carcinoma. Cancer Res 1994; 54: 45957.
  • 9
    Kang GH, Lee S, Kim WH, Lee HW, Kim JC, Rhyu MG, Ro JY. Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 2002; 160: 78794.
  • 10
    Chong JM, Sakuma K, Sudo M, Ushiku T, Uozaki H, Shibahara J, Nagai H, Funata N, Taniguchi H, Aburatani H, Fukayama M. Global and non-random CpG-island methylation in gastric crcinoma associated with Epstein-Barr virus. Cancer Sci 2003; 94: 7680.
  • 11
    Osawa T, Chong JM, Sudo M, Sakuma K, Uozaki H, Shibahara J, Nagai H, Funata N, Fukayama M. Reduced expression and promoter methylation of p16 gene in Epstein-Barr virus-associated gastric carcinoma. Jpn J Cancer Res 2002; 93: 1195200.
  • 12
    Takeichi M. Morphogenetic roles of classic cadherins. Cur Opin Cell Biol 1995; 7: 61927.
  • 13
    Takeichi M. Cadherin cell adhesion receptors as morphogenetic regulator. Science 1991; 251: 14515.
  • 14
    Bracke ME, van Roy FM, Mareel MM. The E-cadherin/catenin complex in invasion and metastasis. In: GuntherU, BirchmeierW, eds. Attempts to understand metastasis formation. Berlin: Springer-Verlag, 1996. 12361.
  • 15
    Shino Y, Watanabe A, Yamada Y, Tanase M, Yamada T, Matsuda M, Yamashita J, Tatsumi M, Miwa T, Nakano H. Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas. Cancer 1995; 76: 2193201.
  • 16
    Shun CT, Wu MS, Lin JT, Wang HP, Houng RL, Lee WJ, Wang TH, Chuang SM. An immunohistochemical study of E-cadherin expression with correlations to clinicopathological features in gastric cancer. Hepato-Gastroenterology 1998; 45: 9449.
  • 17
    Oka H, Shiozaki H, Kobayashi K, Tahara H, Tamura S, Miyata M, Doki Y, Iihara K, Matsuyoshi N, Hirano S, Takeichi M, Mori T. Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch 1992; 421: 14956.
  • 18
    Becker KF, Atkinson NJ, Reich U, Becker I, Nekarda H, Siewert JR, Hofler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54: 384552.
  • 19
    Machado JC, Soares P, Carneiro F, Rocha A, Beck S, Blin N, Berx G, Sobrinho-Simoes M. E-cadherin gene mutations provide a genetic basis of the phenotypic divergence of mixed gastric carcinomas. Lab Invest 1999; 79: 45965.
  • 20
    Tamura G, Sakata K. Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R. Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpn J Cancer Res 1996; 87: 11539.
  • 21
    Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 4025.
  • 22
    Wu MS, Shun CT, Wu CC, Hsu TY, Lin MT, Chang MC, Wang HP, Lin JT. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Gastroenterology 2000; 118: 10318.
  • 23
    Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 2nd English edition. Gastric Cancer 1998; 1: 1024.
  • 24
    Lauren P. The two histological main types of gastric carcinoma, diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965; 64: 3149.
  • 25
    Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpGislands. Proc Natl Acad Sci 1996; 93: 98216.
  • 26
    Kallakury BVS, Sheehan CE, Winn-Deen E, Oliver J, Fisher HAG, Kaufman RP, Ross JS. Decreased expression of catenins (α and β), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas. Cancer 2001; 92: 278695.
  • 27
    Shimoyama Y, Hirohashi S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res 1991; 51: 218592.
  • 28
    Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJG. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 1997; 112: 4654.
  • 29
    Berx G, Becker KF, Hofler H, van Roy F. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998; 12: 22637.
  • 30
    Oda T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W, Sugimura T, Hirohashi S. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci 1994; 91: 185862.
  • 31
    Tamura G, Yin J, Wang S, Fleisher AS, Zou TT, Abraham JM, Kong DH, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, et al. E-cadherin gene promoter hypermethylation in gastric carcinomas. J Natl Cancer I 2000; 92: 56973.
  • 32
    Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simoes M. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 2001; 20: 15258.
  • 33
    Oue N, Motoshita J, Yokozaki H, Hayashi K, Tahara E, Taniyama K, Matsusaki K, Yasui W. Distinct promoter hypermethylation of p16(INK4a), CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas. J Pathol 2002; 198: 559.
  • 34
    Bender CM, Pao MM, Jones PA. Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 1998; 58: 95101.
  • 35
    Joo YE, Rew JS, Kim HS, Choi SK, Park CS, Kim SJ. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers. Digestion 2001; 64: 1119.
  • 36
    Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogenous loss of E-cadherin expression during metastatic progression. J Biol Chem 2000; 275: 272732.
  • 37
    Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, Hofler H, Becker KF. Differential expression of the epithelial-mesenchymal transition regulators Snail, SIP1, and Twist in gastric cancer. Am J Pathol 2002; 161: 188191.
  • 38
    Rashid MG, Sanda MG, Vallorosi CJ, Rios-Doria J, Rubin MA, Day ML. Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate. Cancer Res 2001; 61: 48992.
  • 39
    Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2: 7683.
  • 40
    Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, de Herreros AG. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2: 849.
  • 41
    Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F. The two-handed E box binding zinc finger protein SIP1 down regulates E-cadherin and induces invasion. Mol Cell 2001; 7: 126778.